All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Addex Therapeutics Ltd revenue reports

Addex Therapeutics Ltd financial reports, Addex Therapeutics Ltd annual revenue in 2024. When does Addex Therapeutics Ltd report revenue?
Add to widgets
Added to widgets

Addex Therapeutics Ltd total revenue, net income and dynamics of changes in Swiss franc today

Addex Therapeutics Ltd net revenue for today is 1 071 880 Fr. The dynamics of Addex Therapeutics Ltd net revenue has changed by 149 459 Fr over the last period. Addex Therapeutics Ltd net income is now -4 690 149 Fr. Graph of finance company Addex Therapeutics Ltd. The financial report on the chart of Addex Therapeutics Ltd allows you to clearly see the dynamics of fixed assets. The value of "net income" Addex Therapeutics Ltd on the graph is displayed in blue.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 976 052.86 Fr +74.73 % ↑ -4 270 844.99 Fr -
31/03/2021 839 955.64 Fr +50.36 % ↑ -2 403 628.96 Fr -
31/12/2020 1 722 562.83 Fr +183.35 % ↑ -1 934 937.28 Fr -
30/09/2020 93 474.81 Fr -84.624 % ↓ -3 016 845.45 Fr -
30/06/2019 558 616.97 Fr - -3 433 245.07 Fr -
31/03/2019 558 616.97 Fr - -3 433 245.07 Fr -
31/12/2018 607 926.82 Fr - -1 820 778.21 Fr -
30/09/2018 607 926.82 Fr - -1 820 778.21 Fr -
Show:
to

Addex Therapeutics Ltd financial report charts

The dates of the latest financial statements of Addex Therapeutics Ltd: 30/09/2018, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Addex Therapeutics Ltd is 30/06/2021. Gross profit Addex Therapeutics Ltd is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Addex Therapeutics Ltd is -2 659 959 Fr

Addex Therapeutics Ltd quarterly report dates

Cost of revenue Addex Therapeutics Ltd is the total cost of producing and distributing of products and services of a company. Cost of revenue Addex Therapeutics Ltd is 3 731 839 Fr Total revenue Addex Therapeutics Ltd refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Addex Therapeutics Ltd is 1 071 880 Fr Operating income Addex Therapeutics Ltd is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Addex Therapeutics Ltd is -4 506 637 Fr

Net income Addex Therapeutics Ltd is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Addex Therapeutics Ltd is -4 690 149 Fr Current assets Addex Therapeutics Ltd is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Addex Therapeutics Ltd is 21 000 043 Fr Total assets Addex Therapeutics Ltd refers to the total amount of assets owned by a person or entity. Total assets Addex Therapeutics Ltd is 21 531 609 Fr

30/06/2021 31/03/2021 31/12/2020 30/09/2020 30/06/2019 31/03/2019 31/12/2018 30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-2 422 156.01 Fr -1 662 409.57 Fr -552 711.74 Fr -1 708 559.64 Fr -1 453 486.29 Fr -1 453 486.29 Fr -218 532.83 Fr -218 532.83 Fr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
3 398 208.86 Fr 2 502 365.21 Fr 2 275 274.57 Fr 1 802 034.44 Fr 2 012 103.26 Fr 2 012 103.26 Fr 826 459.65 Fr 826 459.65 Fr
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
976 052.86 Fr 839 955.64 Fr 1 722 562.83 Fr 93 474.81 Fr 558 616.97 Fr 558 616.97 Fr 607 926.82 Fr 607 926.82 Fr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-4 103 739.15 Fr -2 866 591.15 Fr -1 715 257.09 Fr -2 834 723.83 Fr -3 409 112.37 Fr -3 409 112.37 Fr -1 767 720.34 Fr -1 767 720.34 Fr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-4 270 844.99 Fr -2 403 628.96 Fr -1 934 937.28 Fr -3 016 845.45 Fr -3 433 245.07 Fr -3 433 245.07 Fr -1 820 778.21 Fr -1 820 778.21 Fr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - 671 355.50 Fr 671 355.50 Fr 464 280.74 Fr 464 280.74 Fr
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
5 079 792 Fr 3 706 546.79 Fr 3 437 819.92 Fr 2 928 198.63 Fr 3 967 729.35 Fr 3 967 729.35 Fr 2 375 645.34 Fr 2 375 645.34 Fr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
19 122 618.16 Fr 23 918 217.67 Fr 17 747 177.49 Fr 17 527 615.68 Fr 34 143 378.46 Fr 34 143 378.46 Fr 38 382 264.16 Fr 38 382 264.16 Fr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
19 606 661.62 Fr 24 472 108.64 Fr 18 377 537.83 Fr 17 889 957.59 Fr 34 574 501.56 Fr 34 574 501.56 Fr 38 439 879.58 Fr 38 439 879.58 Fr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
16 489 321.56 Fr 22 965 516.22 Fr 17 023 684.73 Fr 16 220 909.76 Fr 33 462 603.72 Fr 33 462 603.72 Fr 37 944 804.20 Fr 37 944 804.20 Fr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 4 011 085.70 Fr 4 011 085.70 Fr 2 125 181.44 Fr 2 125 181.44 Fr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 5 186 752.78 Fr 5 186 752.78 Fr 2 707 373.82 Fr 2 707 373.82 Fr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 15 % 15 % 7.04 % 7.04 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
14 954 517.87 Fr 18 848 552.44 Fr 13 303 672 Fr 14 336 439.70 Fr 29 387 748.78 Fr 29 387 748.78 Fr 35 732 505.76 Fr 35 732 505.76 Fr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -2 101 351.98 Fr -2 101 351.98 Fr -833 249.08 Fr -833 249.08 Fr

Last revenue report of Addex Therapeutics Ltd was 30/06/2021. According to last financial report total revenue in Addex Therapeutics Ltd was 976 052.86 Swiss franc and changed by +74.73% since last year. Net income in Addex Therapeutics Ltd was -4 270 844.99 Fr in last quartal, net income changes to 0%.

Current cash Addex Therapeutics Ltd - the sum of all of the cash a company has on the date of report. Current cash Addex Therapeutics Ltd is 18 108 214 Fr

Addex Therapeutics Ltd stocks data

Addex Therapeutics Ltd financials